Danaher beats Q2 profit estimates on strength in medical testing business
Go back to Danaher beats Q2 profit estimates on strength in medical testing business| Danaher Corp. (NYSE: DHR) | Delayed: 211.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $211.81 | 52 Week High | $102.79 | |||
| Open | $211.81 | 52 Week Low | $75.71 | |||
| Day High | $211.81 | P/E | 55.74 | |||
| Day Low | $211.81 | EPS | $3.80 | |||
| Volume | 601 | |||||

